Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation

被引:30
|
作者
Li-Saw-Hee, FL [1 ]
Blann, AD [1 ]
Edmunds, E [1 ]
Gibbs, CR [1 ]
Lip, GYH [1 ]
机构
[1] Univ Birmingham, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Dept Med, Birmingham B18 7QH, W Midlands, England
关键词
atrial fibrillation; exercise; fibrinogen; von Willebrand factor;
D O I
10.1002/clc.4960240512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is increasing evidence that chronic atrial fibrillation (AF) is associated with a prothrombotic or hypercoagulable state. Hypothesis: This study was undertaken to determine whether short-term exercise in patients with chronic AF would shift the overall hemostatic balance toward a more prothrombotic state with a reduction in fibrinolytic potential. Methods: We recruited 20 patients (13 men; mean age 65 years +/- 11 standard deviation [SDI) with chronic AF who were not treated with antithrombotic therapy and exercised them to exhaustion using a multistage treadmill exercise (standard Bruce) protocol. Blood samples were taken pre exercise, immediately after cessation of exercise, and at 20 min post exercise. The prothrombotic state was quantified by fibrinogen tan index of hemorheology and a coagulation factor), soluble P-selectin (sP-sel, marking platelet activation), von Willebrand factor (VWF, an index of endothelial dysfunction), and plasminogen activator inhibitor-1 (PAI-1, a regulator of fibrinolytic activity) levels. There were two groups of age- and gender-matched controls in sinus rhythm: (1) healthy controls, and (2) "hospital controls" who were patients with vascular disease. Results: Baseline levels of vWf (p = 0.034) and fibrinogen (p < 0.0001), but not sP-sel (p = 0.075) were significantly elevated in patients with AF compared with both control groups in sinus rhythm. The PAI-1 levels were highest in the hospital control patients, but not in chronic AF (p = 0.041). Following treadmill exercise, achieving a mean metabolic equivalent of 4.9 METS (<plus/minus> 1.75 SD) and total exercise duration of 4.9 min (+/- 2 SD), there was a significant rise in plasma fibrinogen (repeated measures analysis of variance [ANOVA] p = 0.037) and a reduction in PAI-1 levels (p = 0.025) in patients with AE There were no significant changes seen in vWf (p = 0.308) or sP-sel (p = 0.071) levels. No significant changes in these indices were seen in hospital controls (all p = not significant). despite a much longer duration of exercise with greater workload. Conclusion: Patients, with chronic AF have increased vWf and fibrinogen levels compared with sinus rhythm. Exercise to exhaustion influences the hypercoagulable state in chronic AF, with a rise in plasma fibrinogen and possible increase in fibrinolytic activity. Nevertheless, acute exercise does not appear to have a significant influence on endothelial dysfunction or platelet activation in patients with AF.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 50 条
  • [21] Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation
    Yee Cheng Lau
    Qinmei Xiong
    Andrew D. Blann
    Gregory Y. H. Lip
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 18 - 23
  • [22] Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation
    Lau, Yee Cheng
    Xiong, Qinmei
    Blann, Andrew D.
    Lip, Gregory Y. H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 18 - 23
  • [23] High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men
    Jilma, B
    Cvitko, T
    Winter-Fabry, A
    Petroczi, K
    Quehenberger, P
    Blann, AD
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 797 - 801
  • [24] Effect of Physical Exercise on Platelet Activity and the von-Willebrand-Factor in Patients with Persistent Lone Atrial Fibrillation
    Andreas Goette
    Mathias Weber
    Uwe Lendeckel
    Tobias Welte
    Gerd Lutze
    Helmut U. Klein
    Journal of Interventional Cardiac Electrophysiology, 2004, 10 : 139 - 146
  • [25] Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation
    Zingariello, M.
    Fabucci, M. E.
    Bosco, D.
    Migliaccio, A. R.
    Martelli, F.
    Rana, R. A.
    Zetterberg, E.
    BIOTECHNIC & HISTOCHEMISTRY, 2010, 85 (03) : 157 - 170
  • [26] Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation
    Uemura, Takashi
    Kaikita, Koichi
    Yamabe, Hiroshige
    Soejima, Kenji
    Matsukawa, Masakazu
    Fuchigami, Shunichiro
    Tanaka, Yasuaki
    Morihisa, Kenji
    Enomoto, Koji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Ogawa, Hisao
    THROMBOSIS RESEARCH, 2009, 124 (01) : 28 - 32
  • [27] Effects of toll-like receptor-4 gene polymorphism on soluble P-selectin von Willebrand factor levels in hypercholesterolemic patients
    Di Nisio, Marcello
    Di Febbo, Concetta
    Moretta, Valeria
    Guglielmi, Maria Domenica
    Stuppia, Liborio
    Cuccurullo, Franco
    Porreca, Ettore
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (03) : 642 - 646
  • [28] Influence of atrial fibrillation on plasma von Willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure
    Freestone, Bethan
    Gustasson, Finn
    Chong, Aun Yeong
    Corell, Pernille
    Kistorp, Caroline
    Hildebrandt, Per
    Lip, Gregory Y. H.
    CHEST, 2008, 133 (05) : 1203 - 1208
  • [29] Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease
    Blann, AD
    Nitu-Whalley, IC
    Lee, CA
    Lip, GYH
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (02) : 135 - 137
  • [30] Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension - A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Spencer, CGC
    Gurney, D
    Blann, AD
    Beevers, DG
    Lip, GYH
    HYPERTENSION, 2002, 40 (01) : 61 - 66